British Business Bank Updates On Companies It Holds Shares From Future Fund Investments crowdfundinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crowdfundinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery,.
ST. CHARLES, Mo., June 23, 2022 /PRNewswire/ Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery
ST. CHARLES, Mo., June 24, 2022 /PRNewswire/ Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a client publication advancing cognitive health research through use of the company's BioMAP Human Phenotypic Profiling and Screening Platform and enzyme assays for neurotransmitter degradation. Published in BMC Complementary Medicine and Therapies, the work of scientists from The Institute for Biomedical and Bioscience Research, University of Buckingham; the European Genomic Institute for Diabetes, Hospital Claude Huriez; and Sibelius Ltd., identifies changes in biomarkers of inflammation and tissue remodeling that result from the use of sage extract on in vitro, human primary cell translational disease models. The work documents applicability of the BioMAP Platform beyond standard biopharmaceutical applications and demonstrates the portfolio breadth of Eurofins Discovery in providing
ST. CHARLES, Mo., June 24, 2022 /PRNewswire/ Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a client publication advancing cognitive health research through use of the company's BioMAP Human Phenotypic Profiling and Screening Platform and enzyme assays for neurotransmitter degradation. Published in BMC Complementary Medicine and Therapies, the work of scientists from The Institute for Biomedical and Bioscience Research, University of Buckingham; the European Genomic Institute for Diabetes, Hospital Claude Huriez; and Sibelius Ltd., identifies changes in biomarkers of inflammation and tissue remodeling that result from the use of sage extract on in vitro, human primary cell translational disease models. The work documents applicability of the BioMAP Platform beyond standard biopharmaceutical applications and demonstrates the portfolio breadth of Eurofins Discovery in providing